Logo
Anaphylaxis Emergency Kit with EpiPen (Epinephrine Auto Injector)

Anaphylaxis Emergency Kit with EpiPen (Epinephrine Auto Injector)

EpiPen

Emergency medical kit
  • EpiPen auto Injectors are licensed medicinal products in many jurisdictions (including MHRA Authorised in the UK and authorised by other national regulatory agencies elsewhere).
  • Manufactured and distributed in accordance with Good Manufacturing Practice (GMP) and pharmacovigilance requirements for medicinal products.
  • Emergency kit containers or pouches themselves are generally considered non Sterile medical accessories or consumer products and may not be individually regulated as medicines.
  • Use of EpiPen should follow national and local clinical guidelines for the management of anaphylaxis, as well as manufacturer Provided instructions and patient information leaflets.
Anaphylaxis emergency kit with epinephrine auto-injector

Description

An anaphylaxis emergency kit with EpiPen is a portable, ready-to-use medical kit designed for individuals at risk of severe allergic reactions (anaphylaxis). At minimum it contains one or more EpiPen (epinephrine) auto-injectors, and often also includes written action instructions and space for additional items such as oral antihistamines, asthma reliever inhalers and emergency contact information. The EpiPen is a pre-filled, single-use auto-injector that delivers a fixed dose of epinephrine intramuscularly, typically into the outer thigh, for rapid treatment of acute anaphylaxis while emergency medical help is sought. Kits are commonly stored at home, school, workplace or carried on the person to ensure epinephrine is immediately available in the event of exposure to known allergens (e.g. foods, insect stings, medications).

Bnefits

  • Provides immediate access to epinephrine, the first-line treatment for severe allergic reactions (anaphylaxis).
  • Portable and easy to recognise in an emergency, improving the chance that epinephrine is administered quickly.
  • Pre-filled auto-injector device designed for rapid use by trained patients or caregivers, without the need to measure doses.
  • Can be customised to include other important items such as oral antihistamines, reliever inhalers, a written anaphylaxis action plan and emergency contact details.
  • Helps patients, families, schools and workplaces organise and centralise critical anaphylaxis supplies in one clearly labelled kit.
  • Supports adherence to allergy specialist recommendations and school/workplace policies on anaphylaxis preparedness.

Indications

  • For use in individuals diagnosed as at risk of anaphylaxis due to allergies to foods, insect stings, medications, latex, or other triggers, as determined by a qualified healthcare professional.
  • Emergency self-treatment (or caregiver treatment) of acute anaphylaxis symptoms such as difficulty breathing, throat tightness, swelling of tongue or lips, widespread hives, collapse or severe hypotension, as instructed by a prescriber.
  • Use in community settings (home, school, work, travel) where immediate access to epinephrine is recommended as part of an individual’s anaphylaxis management plan.

Composition

  • One or more EpiPen epinephrine auto-injectors (commonly 0.3 mg for adults and some children, or 0.15 mg paediatric strength as prescribed).
  • Emergency kit container (e.g. rigid box, soft pouch, or clearly labelled bag) designed to protect the contents and keep them together.
  • Space to include or store additional items such as: oral antihistamine tablets/syrup (as prescribed), asthma reliever inhaler and spacer (if the patient has asthma), glucose source if indicated, and a written anaphylaxis action plan.
  • Printed instructions or checklist (may be supplied by a clinic, allergy service, school or workplace) detailing recognition of anaphylaxis symptoms and step-by-step response, including calling emergency medical services.
  • Optional: identification card or label indicating the owner’s name, allergies, and emergency contacts.

Formulation

  • EpiPen auto-injector: pre-filled, single-use, spring-activated device containing a sterile solution of epinephrine for intramuscular injection into the outer thigh through clothing if necessary.
  • Active ingredient: epinephrine (adrenaline).
  • EpiPen medicinal formulation typically includes epinephrine in a sodium chloride solution with stabilisers and preservatives in a sterile, pyrogen-free aqueous vehicle (exact components vary by product licence and region).
  • Emergency kit itself has no pharmacological formulation; it is an organisational container for the medicinal product and associated items.

Packaging

  • EpiPen units: supplied individually or in packs (commonly packs of 2 auto-injectors) in protective cartons with device-specific patient information leaflets.
  • Emergency kit: may be a dedicated anaphylaxis kit box or pouch purchased separately, often brightly coloured and clearly labelled (e.g. “Anaphylaxis Kit” or “EpiPen Inside”), with compartments to secure auto-injectors and other supplies.
  • Some commercial emergency kits may be sold as pre-assembled sets including an appropriate pouch and one or more EpiPen devices, while others are assembled by the patient, family, school or workplace using prescribed EpiPen units and a general-purpose medical pouch.

Usage

  • EpiPen auto-injectors must only be used by or for individuals who have been prescribed epinephrine by a qualified healthcare professional and trained in recognition of anaphylaxis and device use.
  • In the event of signs of anaphylaxis (e.g. difficulty breathing, throat tightness, swelling of tongue or lips, wheeze, persistent cough, dizziness, faintness, or collapse), follow the individual’s anaphylaxis action plan.
  • Remove the EpiPen from its carrier tube, hold it in the dominant hand as instructed (usually with the orange/needle end pointing down), remove the safety cap(s), and press firmly into the outer mid-thigh until the device activates, holding in place for the prescribed number of seconds (per patient leaflet and training).
  • Call emergency medical services immediately after administering epinephrine (or as directed by the action plan) and inform them that epinephrine has been given.
  • If symptoms do not improve or recur, a second EpiPen may be administered according to medical advice and local guidelines, typically after a defined interval, using a new auto-injector in a different injection site on the thigh.
  • Lay the person flat with legs elevated (or in a position that makes breathing easier) unless there is vomiting or difficulty breathing that requires a different posture, and keep them under observation until medical help arrives.
  • Do not delay the use of epinephrine when anaphylaxis is suspected; epinephrine is considered first-line treatment in anaphylaxis.
  • Ensure all caregivers, school staff, workplace first-aiders and family members know where the emergency kit is stored and how to use it, and review the plan regularly.
  • Follow device-specific instructions provided in the official patient information leaflet and any training materials supplied by the prescriber or manufacturer.
  • Used EpiPen devices must be safely disposed of according to local sharps disposal regulations; do not re-use or attempt to refill auto-injectors.

Contraindications

  • In the context of life-threatening anaphylaxis, there are effectively no absolute contraindications to the use of epinephrine; the risk of not treating anaphylaxis is generally greater than the risks associated with epinephrine.
  • Relative cautions exist in individuals with certain cardiovascular conditions (e.g. severe heart disease, arrhythmias, hypertension) in non-emergency contexts, but in anaphylaxis epinephrine remains the recommended first-line treatment as per specialist and guideline advice.
  • Use only in individuals for whom a healthcare professional has recommended an epinephrine auto-injector and provided an action plan.
  • Do not inject into areas other than the recommended outer thigh muscle (e.g. do not inject into hands, fingers, buttocks, or veins).
  • Do not use devices that are expired, damaged, discoloured, or have visible particulate matter in the solution; replace them as advised by a healthcare professional.

Adverse Effects

  • Common transient side effects of epinephrine can include palpitations, rapid heart rate (tachycardia), anxiety, tremor, headache, dizziness, sweating and pallor.
  • Other possible effects include increased blood pressure, nausea, vomiting and feelings of nervousness or restlessness.
  • At higher doses or in susceptible individuals, more serious cardiovascular effects (e.g. arrhythmias, chest pain, significant hypertension) can occur; this is one reason why administration should be followed by urgent medical assessment.
  • Local injection site reactions such as pain, swelling, bruising, or irritation can occur at the injection site.
  • Accidental injection into hands or fingers can cause local vasoconstriction, which may require urgent medical attention.
  • All suspected adverse reactions to EpiPen should be reported to a healthcare professional and through local pharmacovigilance systems as appropriate.

Storage Conditions

  • Store EpiPen auto-injectors at room temperature within the range specified in the official product information (commonly around 15–25 °C); avoid freezing or exposing to excessive heat.
  • Keep the auto-injector in its protective outer tube and inside the emergency kit pouch or container to reduce light exposure and physical damage.
  • Do not store EpiPen in a vehicle glove box or other places subject to extreme temperatures.
  • Regularly check the solution in the viewing window; it should be clear and colourless. Replace the device if the solution is discoloured or contains particles, or if the expiry date has passed.
  • Keep the emergency kit in an easily accessible, clearly labelled location that is known to all relevant caregivers, school staff or colleagues.
  • Store out of the reach of small children, while ensuring it can be quickly accessed in an emergency by trained individuals.

Duration

The emergency kit and EpiPen auto-injectors are not for continuous daily use; they are used episodically, only at the time of an acute anaphylactic reaction. The kit should be maintained indefinitely as long as the individual remains at risk, with EpiPen devices replaced before their stated expiry date or sooner if damaged or discoloured. Emergency kit contents and expiry dates should be reviewed regularly (for example every few months).

Onset

Epinephrine delivered via EpiPen auto-injector acts rapidly; clinical effects on circulation and airway are generally expected within minutes of intramuscular injection into the outer thigh. However, response time and degree of improvement vary between individuals and according to the severity of the reaction, and emergency medical assessment is always required after use.

Browse more Emergency medical kit

Top Treatments

Top Cities in the UK